Tumor markers in screening, diagnosis and treatment of patients with breast carcinoma
Thomas, C.M.; Wobbes, T.; Bonfrer, J.M.; Peterse, J.L.; Nap, M.; Beex, L.V.
Nederlands Tijdschrift Voor Geneeskunde 137(46): 2354-2357
1993
ISSN/ISBN: 0028-2162 PMID: 8264818 Document Number: 407385
Document emailed within 1 workday
Related Documents
Groenendijk, R.P.; Bult, P.; Wobbes, T. 2004: Better prognosis and favorable tumor stages in patients with invasive breast mammary carcinoma after introduction of the mass screening of breast cancer in Tilburg, the Netherlands Nederlands Tijdschrift Voor Geneeskunde 148(19): 961; Author Reply 961-2Schuurman, J.J.; Bong, S.B.; Einarsson, R. 1996: Determination of serum tumor markers TPS and CA 15-3 during monitoring of treatment in metastatic breast cancer patients Anticancer Research 16(4b): 2169-2172
Crombach, G. 1998: Considerations in rational use of tumor markers in breast carcinoma Praxis 87(17): 589-594
Hou, J.-X.; Yang, X.-Q.; Chen, C.; Jiang, Q.; Yang, G.-L.; Li, Y. 2011: Screening the gastric cancer related tumor markers from multi-tumor markers protein chip with kappa coefficient and cost-effectiveness analysis Hepato-Gastroenterology 58(106): 632-636
Yu, S.Y. 1987: Fuzzy identification of tumor markers: evaluation of the diagnosis and differential diagnosis of primary hepatic carcinoma Zhonghua Nei Ke Za Zhi 26(10): 584-586; 622
Holder, W.D.; Wells, S.A. 1983: Antibody reacting with the murine mammary tumor virus in the serum of patients with breast carcinoma: a possible serological detection method for breast carcinoma Cancer Research 43(1): 239-244
Mahler, B. 2008: Tumor markers used in diagnosis and monitoring of primary bronchopulmonary carcinoma Pneumologia 57(3): 175-177
de Oliveira e Silva, A.; Roldan-Molina, F.; dos Santos, T.E.; Santo, G.C.; Miranda, M.P.; Genzini, T.; Neves, L.B.; D'Albuquerque, L.A. 1990: Diagnosis of hepatocellular carcinoma performed by searching for serologic tumor markers Arquivos de Gastroenterologia 27(2): 83-94
Lipská, L.; Visokai, V.; Levý, M.; Svobodová, Sárka.; Kormunda, S.; Fínek, J. 2007: Tumor markers in patients with relapse of colorectal carcinoma Anticancer Research 27(4a): 1901-1905
Mangkharak, J.; Patanachak, C.; Podhisuwan, K.; Pleehachinda, R. 1997: The evaluation of combined scintimammography and tumor markers in breast cancer patients Anticancer Research 17(3B): 1611-1614
Lavialle, C.; Modjtahedi, N.; Lamonerie, T.; Frebourg, T.; Landin, R.M.; Fossar, N.; Lhomond, G.; Cassingena, R.; Brison, O. 1989: The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review) Anticancer Research 9(5): 1265-1279
Xing, Y.; Zhao, J.-h.; Wang, T.-s.; Qiao, W.-l.; Che, W.-j. 2009: The role of 18F-FDG SPECT-CT in detecting recurrence and metastases in breast cancer patients with elevated tumor markers Zhonghua Zhong Liu Za Zhi 31(2): 129-133
Hiura, M.; Yorishima, M.; Tanaka, M.; Yokoyama, T.; Myoga, H.; Chiba, T.; Nakanishi, Y. 1990: A clinical study on multiple tumor markers following therapy in patients with uterine cervical carcinoma Nihon Sanka Fujinka Gakkai Zasshi 42(5): 471-478
Coventry, B.J.; Weeks, S.C.; Heckford, S.E.; Sykes, P.J.; Bradley, J.; Skinner, J.M. 1996: Lack of IL-2 cytokine expression despite Il-2 messenger RNA transcription in tumor-infiltrating lymphocytes in primary human breast carcinoma: selective expression of early activation markers Journal of Immunology 156(9): 3486-3492
Braga, M.; Pinelli, D.; Filippini, L.; Ragni, F.; Piccini, P.I.; Pezzola, D.; Bianchi, A.M.; Perna, E. 1996: Impact of a screening program on the surgical treatment of breast carcinoma Minerva Chirurgica 51(12): 1095-1106
Peng, J.; Cai, S.; Leng, X.; Mu, D.; Lu, J.; Chen, H.; Rui, J. 2002: MRNA of MAGE genes as specific markers in detection of tumor cells in the peripheral blood of patients with hepatocellular carcinoma Zhonghua Yu Fang Yi Xue Za Zhi 36(7): 487-490
Kokhanenko, N.I.; Ignashov, A.M.; Varga, E.V.; Polkanova, M.S.; Aleshina, L.A.; Kimbarovskaia, A.A.; Osipenko, S.K.; Lebedev, E.G. 2001: Role of the tumor markers CA 19-9 and carcinoembryonic antigen (CEA) in diagnosis, treatment and prognosis of pancreatic cancer Voprosy Onkologii 47(3): 294-297
Rosen, P.P. 1983: Tumor emboli in intramammary lymphatics in breast carcinoma: pathologic criteria for diagnosis and clinical significance Pathology Annual 18 Pt 2: 215-232
Zissimopoulos, A.; Matthaios, D.; Matthaiou, E.; Mantadakis, E.; Karaitianos, I. 2007: Association between bone scintigraphy and serum levels of tumor markers in the detection of bone disease in breast cancer patients Journal of BUON: Official Journal of the Balkan Union of Oncology 12(4): 505-511
Dohrmann, P.J.; Hughes, E.S.; McDermott, F.; Price, A. 1982: Symptom duration, tumor staging and survival in patients with carcinoma of the breast Surgery Gynecology and Obstetrics 154(5): 707-710